Champions Oncology announces board changes
This article was originally published in Scrip
Champions Oncology, which develops technology solutions for personalized use of oncology medicines, has appointed Dan Mendelson and Arthur Epker to its board of directors. Mr Mendelson currently serves as chief executive officer and founder of strategic advisory firm, Avalere Health and an adjunct professor of business administration at the Fuqua School of Business, Duke University. He also sits on the boards of Coventry Health Care and HMS Holdings. Presently, Mr Epker serves as vice-president and partner of PAR Capital Management. He is a current director of Pure Cycle Corporation, the Steppingstone Foundation and the Winsor School. In conjunction with these appointments, Ana Stancic has resigned from the Champions board of directors. Furthermore, Scott Tobin, a current director of the company, has assumed the role of chair of the audit committee.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.